Adalimumab 产品
(Adalimumab)
Categories
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended Adalimumab 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
ELISA, IGA
Validations
Cat. No.
ABIN7515206
Quantity
40 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA
Validations
Cat. No.
ABIN7514455
Quantity
40 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, BP
Validations
Cat. No.
ABIN7514454
Quantity
40 μg
Datasheet
Datasheet
Recommended Adalimumab ELISA试剂盒
Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Chemical, Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
Cat. No.
ABIN2862650
Quantity
96 tests
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Analytical Method
Quantitative Sandwich ELISA
Validations
Cat. No.
ABIN4886389
Quantity
96 tests
Datasheet
Datasheet
Latest Publications for our Adalimumab Products
: "Efficacy of a concomitant elemental diet to reduce the loss of response to adalimumab in patients with intractable Crohn's disease." in: Journal of gastroenterology and hepatology, Vol. 33, Issue 3, pp. 631-637, (2018) (PubMed).: "IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA." in: Journal of molecular medicine (Berlin, Germany), Vol. 95, Issue 11, pp. 1227-1236, (2018) (PubMed).
: "Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease." in: Alimentary pharmacology & therapeutics, Vol. 45, Issue 8, pp. 1135-1145, (2017) (PubMed).
: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." in: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).
: "Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study." in: Pediatric gastroenterology, hepatology & nutrition, Vol. 19, Issue 2, pp. 116-22, (2016) (PubMed).
: "Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation." in: Scandinavian journal of gastroenterology, Vol. 51, Issue 2, pp. 196-202, (2016) (PubMed).
: "Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: a useful cutoff in clinical practice." in: The American journal of gastroenterology, Vol. 110, Issue 3, pp. 472-3, (2015) (PubMed).
: "Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease." in: Journal of gastroenterology, Vol. 50, Issue 7, pp. 758-68, (2015) (PubMed).
: "Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease." in: Gut, Vol. 63, Issue 2, pp. 272-80, (2014) (PubMed).
: "Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children." in: Inflammatory bowel diseases, Vol. 20, Issue 3, pp. 495-501, (2014) (PubMed).
You are here:
